Trials / Unknown
UnknownNCT02399358
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide: Prospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Diego Hernan Giunta, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospoctive cohort of high-dose cyclophosphamide exposed patients. With active estandardize screening of hyponatremia development in the follow up period.
Detailed description
Primary objectives 1. To identify the factors associated with the development of hyponatremia in patients receiving high-dose cyclophosphamide (2.5 grams or more). 2. Generate and validate a predictive score of developing hyponatremia high-dose cyclophosphamide. 3. To estimate the incidence of hyponatremia in patients undergoing high-dose cyclophosphamide. Study design. Observational prospective cohort study of Patients after infusion of high-dose cyclophosphamide. Follow up period will be from cyclophosphamide infusion until one month after hospital discharge.
Conditions
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-06-01
- Completion
- 2017-11-01
- First posted
- 2015-03-26
- Last updated
- 2015-12-17
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT02399358. Inclusion in this directory is not an endorsement.